MISTY MOORE IVY: Open Payments
NPI 1063465482 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 27 payments from 15 companies in 2025. Trend: 2023 $1,172 · 2024 $1,158 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 4 | $175 |
| Kerecis Limited | 4 | $88 |
| Organogenesis Inc. | 2 | $72 |
| Lilly USA, LLC | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55 |
| ABBVIE INC. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| GENZYME CORPORATION | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
| UCB, Inc. | 1 | $27 |
Products named: VTAMA, Kerecis SurgiClose, TALTZ, DUPIXENT, ILUMYA, COSENTYX, CYGNUS DUAL, NOVACHOR.
Industry payments across MS — which companies pay providers there.
